Drug reference
echothiophate
Organophosphate cholinesterase inhibitor · Antiglaucoma Agent (ophthalmic)
Organophosphate cholinesterase inhibitorAntiglaucoma Agent (ophthalmic)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Echothiophate is an extremely potent choline derivative and organophosphorus compound. It inhibits acetylcholinesterase by forming a stable, phosphorylated conjugate with the active center serine.
Indications
glaucomaaccommodative esotropiaaccommodative strabismuslong acting miotic (formerly used)
Pharmacokinetics
Duration
Long-acting (implied by use as long-acting topical ChE inhibitor)
Bioavailability
As a positively charged quaternary amine, it is not volatile, does not readily penetrate the skin, and its quaternary ammonium group restricts entry into the CNS.
Side effects
Common
miosiscataractpupillary blockiris cystsbrow achepunctal stenosis
Serious
- retinal detachment
- glaucoma
Related guidelines
Ask House about echothiophate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team